Cormet Large Diameter Metal on Metal (LDMOM) Total Hip System (G030265)
NCT ID: NCT00867256
Last Updated: 2023-09-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
195 participants
INTERVENTIONAL
2004-03-31
2009-04-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ceramic-on-Ceramic Total Hip Arthroplasty and Squeaking: Influence of Component Design
NCT01420900
A Validated Necrosis Assay to Determine the Need for Revision Surgery in Metal-on-metal Total Hip Arthroplasty
NCT02208271
PMCF Study of MOTIVATION HIP System in THA
NCT03892005
Metal on Metal Versus Metal on Highly Crossed Linked Polyethylene Sytem
NCT01422564
CoMplete™ Acetabular Hip System
NCT01543230
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Large Diameter Metal on Metal
Large Diameter Metal on Metal
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Large Diameter Metal on Metal
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* is skeletally mature
* is mentally capable of completing follow-up forms
* will be available for follow-up out to 2 years
* has a preoperative Harris Hip Score \<70 points
* has been deemed a candidate for hip replacement by diagnosis of the investigator.
Exclusion Criteria
* has active joint infection
* has had previous hip arthrodesis (fusion)
* has had above knee amputation of either extremity
* has active neoplastic disease
* has a need for a structural bone graft in the operative side
* has an ipsilateral hemi or total arthroplasty of any kind
* has a nonunion or malunion of any part of the femur on operative side
* has severe osteoporosis of the pelvis and/or femur as noted on standard radiograph
* is a prisoner
* is pregnant
* is known to be allergic to implant materials
* is morbidly obese.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Corin
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giulia Carli
Role: STUDY_DIRECTOR
Corin Ltd
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LDMOM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.